News

Do You Believe in the Growth Potential of Tempus AI (TEM)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second-quarter ...
Zacks Investment Research on MSN2d
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
Tempus AI TEM jumped 7.3% at yesterday’s close after securing FDA 510(k) clearance for its ECG-Low EF software, its second greenlighted AI tool in cardiology. The approval adds fuel to a stock already ...
Crain's Chicago Business2d
Tempus gets FDA OK for software to detect cardiac issue
The new Tempus software analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with having a low ...
Tempus AI, Inc. (TEM) and Personalis Join Forces to Take on Colorectal Cancer
Tempus AI, Inc. (NASDAQ:TEM) announced an update about its strategic partnership with Personalis. Under this expansion, the company added colorectal cancer to it ...
Medical Device Network on MSN3d
FDA grants 510(k) clearance for Tempus AI’s ejection fraction software
The US Food and Drug Administration (FDA) has granted 510 (k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software. This software utilises AI to detect individuals with a low left ...
The Bakersfield Californian3d
TEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of ...
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 12, 2025 to file lead plaintiff applications in a ...
From Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in Medicine
AI could inject an additional $461 billion into the healthcare sector by 2035, according to Accenture, as it races past the ...
Tempus AI Stock Is Rising Wednesday: What's Happening?
Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday after the company announced that it received 510(k) clearance ...